Skip to main content

Table 1 Membership of the scientific board and Delphi respondents

From: Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts

Participating experts

Number

Specialty, n (%)

Hospital-based, n (%)1

University-based, n (%)1

Geographical origin, n (%)

Scientific board

10

Rheumatology, 9 (90)

Pediatrics, 1 (10)

6 (60)

8 (80)

Northern Italy, 7 (70)

Central Italy, 2 (20)

Southern Italy, 1 (10)

Bibliographic board

4

Rheumatology (100)

2 (50)

3 (75)

Northern Italy, 3 (75)

Central Italy, 1 (25)

Delphi respondents

49

Rheumatology (100)

22 (45)

43 (88)

Northern Italy, 20 (41)

Central Italy, 18 (37)

Southern Italy, 11 (22)

  1. 1Percentages do not add to 100 because some experts are both hospital- and university-based